Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

PCOS affects nearly 25% of female medical and dental students, impacting their academic and social lives.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Aging causes hair to gray and thin, with the timing of graying varying by race, and factors like oxidative stress and genetics can lead to hair loss.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

The document concludes that early diagnosis is key for treating common baldness in women, but reassurance is often the best approach as hair thinning can be a normal part of aging.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.